Gastroenterology

A 54-year-old male with a history of multiple autoimmune arthritides was admitted following a 3-week history of progressive dysphagia with odynophagia…

The inflammatory bowel diseases (IBD) are a group of conditions characterised by chronic, incurable inflammation in the gastrointestinal (GI) tract…

Inflammatory myofibroblastic tumour (IMT) is a rare mesenchymal solid tumour commonly documented in children and young adults, but also found…

IBD is not one disease, but, rather, a whole range of diseases. It is a systemic immune disorder; therefore, in addition to causing conventional…

A paradigm shift has occurred in IBD management, whereby reducing inflammation and mucosal healing has become a the key endpoint that clinicians…

This satellite symposium took place on 7th March 2019, as part of the 14th Congress of the European Crohn’s and Colitis Organisation (ECCO) in Copenhagen…

A highly interactive symposium, including pre-recorded interviews with patients, was chaired by Prof Geert D’Haens. Participation by the audience was…

IBD shows a progressive immunopathogenesis.1 Following an initial immune response, amplification of this inflammatory response leads to the phenotypic…

The epidemiology of diverticular disease (DD) is changing, with an increasing prevalence in younger patients from Europe and the USA, and changing disease…

Despite the fact that the treatment armamentarium for inflammatory bowel diseases (IBD) is growing, unmet medical needs remain…

The objectives of the symposium were to raise awareness of the importance of treating early, setting treatment goals, and using enhanced clinical…

Chemotherapy-induced mucositis is a common, often severe, side effect experienced by cancer patients during their treatment, which is a major challenge…

Colon cancer remains one of the leading causes of cancer-related morbidity and mortality worldwide and it is generally accepted that most colorectal…

The prevalence of non-cardiac chest pain (NCCP) ranges from 13–33%. A majority of those presenting with a chief complaint of chest pain are found to have…

Over the last half century, radiotherapy has been established as a very effective treatment modality for solid tumours. Large numbers of patients…

Infantile colic is a frustrating impasse that affects up to 20% of infants. Even though its pathogenesis is currently unknown, some…

Magnetic resonance cholangiopancreatography (MRCP) is an important diagnostic tool in evaluating patients with biliary laboratory abnormalities after…

Considering patient-reported outcomes (PRO) for optimal disease management is pivotal in many chronic diseases, and inflammatory bowel disease (IBD) is…

This symposium focusses on understanding the advantages and limitations of current management strategies for Crohn’s disease.

Inflammatory bowel disease (IBD) has a dramatic impact on patients and their families, as well as on society as a whole due to its significant economic…

The current treatment strategy for patients with inflammatory bowel disease (IBD) aims to enable physicians to deliver optimal care and to improve the…

Biosimilars have contributed substantially to the evolving therapeutic landscape for inflammatory bowel disease (IBD), enabling healthcare systems to…

Gastric cancer is the second most common cause of cancer-related deaths worldwide, and the 5-year overall survival rate for advanced gastric cancer is ≤25%.

Do flares of ulcerative colitis (UC) cause long-term bowel damage? Dr Sandborn opened the symposium by challenging the audience to think about their…